TWiV 744: COVID-19 clinical update #58 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #58, Daniel Griffin provides the latest update on the J&J vaccine pause, healthcare worker deaths, children and COVID, physical inactivity associated with higher risk, using monoclonal antibodies for prophylaxis, and shows us how to properly wear a face mask.</p> <p>Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></p> <p>Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>Healthcare worker <a href= "https://www.theguardian.com/us-news/2021/apr/08/us-health-workers-deaths-covid-lost-on-the-frontline"> deaths</a> (Guardian)</li> <li>Children and adolescent <a href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2778347"> disease severity</a> (JAMA)</li> <li>Physical inactivity and <a href= "https://bjsm.bmj.com/content/early/2021/04/07/bjsports-2021-104080"> increased disease risk</a> (BMJ)</li> <li>Expansion of Pfizer/BioNTech EUA (<a href= "https://cdn.pfizer.com/pfizercom/2021-04/EUA-12-15yo-Statement-9-April-2021.pdf?VersionId=Vg2h9d1M1XTo58jO8UIogPxXeLcn27cH">pdf</a>)</li> <li><a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2104882">Thrombosis</a> after ChAdOX1 vaccine (NEJM)</li> <li>Your <a href= "https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/about-face-coverings.html"> guide to masks</a> (CDC)</li> <li>Phase 3 mAb <a href= "https://investor.regeneron.com/news-releases/news-release-details/phase-3-prevention-trial-showed-81-reduced-risk-symptomatic-sars"> prevention trial</a> (Regeneron)</li> <